Loading [Contrib]/a11y/accessibility-menu.js

This website uses cookies

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.

Skip to main content
null
CRO Journal
  • Menu
  • Articles
    • CE Credit - Case Report(s)
    • CE Credit - Case Report(s) & Topic Review
    • CE Credit - Clinical Study
    • CE Credit - Cohort Study
    • CE Credit - Methods/Product Review
    • CE Credit - Survey/Report
    • CE Credit - Topic Review
    • Editorial
    • Topic Review
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Blog
  • CE Courses
  • Sponsors
  • search
  • LinkedIn (opens in a new tab)
  • RSS feed (opens a modal with a link to feed)

RSS Feed

Enter the URL below into your favorite RSS reader.

https://clinicaloptometry.scholasticahq.com/feed
ISSN 2816-7988
CE Credit - Case Report(s) & Topic Review
September 28, 2026 EDT

MEK Inhibitor-Associated Retinopathy Secondary to the Use of Trametinib

Steve Njeru, OD, MS, FAAO, ABCMO,
BRAF mutationMEK inhibitorSubretinal fluidTrametinibMEK inhibitor-associated retinopathy
Copyright Logoccby-nc-4.0 • https://doi.org/10.57204/001c.171658
CRO Journal
1.
Njeru S. MEK Inhibitor-Associated Retinopathy Secondary to the Use of Trametinib. CRO Journal. Published online September 28, 2026. doi:10.57204/001c.171658
Save article as...▾

View more stats

Powered by Scholastica, the modern academic journal management system